---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-028031"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2023-03-02T23:59:59+00:00"
generated_at: "2026-06-18T14:00:14.982340+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Novavax President of R&D Dr. Gregory Glenn to retire effective March 31, 2023

## Summary
- Dr. Gregory M. Glenn notified Novavax of his retirement as President, Research and Development.
- Retirement effective March 31, 2023; he will become Strategic Research & Development Advisor.
- No successor named in the filing; consulting services to follow retirement.

## SEC filing metadata
- accession: 0001104659-23-028031
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2023-03-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465923028031/0001104659-23-028031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465923028031/tm238420d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-028031
- JSON: https://secwatch.observer/filing/0001104659-23-028031.json
- Plain text: https://secwatch.observer/filing/0001104659-23-028031.txt

## Key facts
- Executive change
  Dr. Gregory M. Glenn retired as President, Research and Development at NOVAVAX INC.
  - Action: retired
  - Role: President, Research and Development
  source text: On February 28, 2023, Dr. Gregory M. Glenn, M.D. notified Novavax Inc. (the “Company”) of his decision to retire as President, Research and Development, effective as of March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923028031/0001104659-23-028031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.